Abstract
Introduction
Introduction of topical corticosteroids (TC) by Sulzberger and Witten in 1952 is considered to be the most significant landmark in the history of dermatology. 1 This historical event was gradually followed by the introduction of a large number of newer TC molecules of varying potency rendering the therapy of various inflammatory cutaneous disorders more effective and less time consuming. The easy availability of glucocorticosteroids and their potent anti-inflammatory, anti-proliferative effects further added to their widespread use in dermatology and thus led to the emergence of a new therapeutic era in dermatology. Although, the usefulness of this topical medication has become a double-edged sword. The same mechanisms of action responsible for the improvement of dermatologic inflammatory conditions can cause adverse effects when used inappropriately and for longer duration. The excessive and prolonged use of topical corticosteroid on the face is a common problem, often producing an array of cutaneous complications apart from the systemic side effects, including cutaneous atrophy, telangiectasia, striae, purpura, easy bruisability, steroid aggravated acne, perioral dermatitis, steroid rosacea, hypertrichosis and disorders of pigmentation, collectively described as topical steroid damaged facies (TSDF). 2, 3 Despite of the widely prevalent steroid phobia, misuse of topical corticosteroid on face still continues to occur. The facial skin is thinner than the skin of most other parts of the body. This results in increased percutaneous absorption of drugs.
2,3
The sebaceous glands on the face are larger than elsewhere, 4 and there is an increased tendency to sweating particularly in hot and humid climates as is prevalent in most parts of India. The face is also the most visible part of the human body making it vulnerable to the ill-effects of beauty treatments, and injudicious use of various substances like TC and cosmetics. 5 The abuse of topical steroids in India is occurring at various levels and includes misuse at manufacturing and marketing level, prescription misuse and misuse by lay person. Thus both educational and legal approaches need to go hand in hand to curb this evil. In January 2007 the IADVL Central Council and General Body in Chennai unanimously passed the landmark proposal to "Stop OTC supply of potent topical steroids". But till the moment, the end users of steroid are not aware, these steps are in vain. Through our study we tried to counsel the patients about TC misuse, and the need to adhere strictly to the dermatologist's prescription if they have been prescribed for specific dermatosis. We also discouraged them for self-application of these topical drugs. Duration of application was from 1 month to <6 months in majority (Table 3) . We also ascertained the suggestion or recommendation regarding the misuse of these creams and found that in majority of the patients, these were prescribed by friends, relatives and neighbours in 206 (64%), by self in 32 (9.94%), chemists in 29 (9.01%), RMPs in 26 (8.07%), MBBS doctors in 21 (6.52%), interestingly in 8 (2.48%) patients it was from MD/MS doctors including dermatologists. All the 322 (100%) patients were unaware about the side effects of topical steroid. In 300 (93.17%) cases source of procurement was from chemists, in 20 (6.21%) from Registered medical practitioners and in 2 (0.62%) from dispensary. The popular TCs brands are shown in Table 4 , and different formulations used by the patients are highlighted in Table 5 .The common clinical presentations are highlighted in Table 6 , which also include 63(19.57%) patients with combined presentations. All the patients were educated about side effects of steroid and TCS was tapered off or replaced with mild steroid and stopped completely. 
Material and Method

Discussion
The lure for TC is on the rise owing to the rapidity of symptomatic relief that the patient gets in almost any dermatosis. Moreover, TC have acquired a reputation as anti-acne, anti-blemish and fairness creams in the general population, especially in countries with darker-pigmented races. 6 In India, the problem is even more complex, wherein anyone can easily get a class I or II TC without the need to get it prescribed by a physician. In our study we found that most vulnerable age group involved was between 20-39 years (66.77%) and266 (82.61%) patients were females emphasising the fact that most TC misuse is occurring in the age group most concerned for facial appearance thus falling victims of the beauty and fairness craze. That is why ever since the invention, face has remained the commonest site of such misuse. About 177 (54.97%) patients belonged to rural area. Absence of qualified dermatologists, and poorer access to health facilities may be held responsible for this figure in rural areas. But still we found that about 34.47% of patients were graduates followed by about 22.67% who had education up to higher secondary level. These figures are eye opener, proving that even educated youth in this part of our country are falling victim to this problem. Basic purpose of starting the steroid cream in 167 (51.86%) patients was for treatment of melasma, to get free of so called "blemishes" followed by their use for treating acne in 113 (35.09% Most of the patients 162 (50.31%) have used TC for an average duration of one to six months and maximum duration was upto 10 years. We observed in the present study that the suggestions to use them were given by friends, relatives and neighbours in 206 (64%), self-use in 32 (9.94%), chemists in 29 (9.01%), RMPs in 26 (8.07%), MBBS doctors in 21 (6.52%), interestingly in 8 (2.48%) patients it was from MD/MS doctors including dermatologists. The inappropriate use of TC for varied dermatological disorders like acne, bacterial and fungal infections, undiagnosed skin rash and as fairness cream by practitioners of alternative medicine (RMP) in 26 (8.07%) or on the advice of pharmacist in 29 (9.01%) at chemist shops is of more serious concern as these people are not qualified and competent to treat dermatological disorders and prescribe topical steroids which often provide quick but temporary symptomatic relief without treating the underlying pathology of the disease. But important aspect here is that even MBBS doctors in 21 (6.52%) have prescribed it without specific indications emphasising the need of the hour to have a special mention regarding usage of TC in medical undergraduate curriculum. A prescription by a dermatologist must also be complete in terms of duration and quantity to be used, and must be followed by proper counselling. In 300 (93.17%) patients, source of procurement was from chemist and in 20 (6.21%) cases it was from RMPs. The main reason for this is that these creams and ointments are available over the counter and are sold without a prescription, which is not the case in most parts of the world. Ineffective implementation of regulations or laws by regulatory authorities and poorly developed pharmacovigilance practices in India has helped in the past to allow the manufacture and the sale of these fixed-dose combinations (FDCs), which continue to harm skin health. Recently an important step in this regard has been taken by Ministry of Health and Family Welfare of the Government of India through Gazette notification on March 10, 2016, wherein orders have been issued that certain fixed-dose combinations of drugs has the potential to cause a risk to human beings and the said drugs were found to have no therapeutic justification and thus prohibiting the manufacture of certain FDCs with immediate effect. 11 Unfortunately, we found that most of the subjects were using potent TC in our study, which is in concordance with prior studies from other countries. 6 In our study, most common clinical presentation thus was steroid induced rosacea in 179 (55.6%), followed by steroid aggravated acne in 44 (13.66%). In our study, the main responsibility for the misuse of topical corticosteroids can be attributed to the pharmacists, paramedical personnel, patient himself/herself, friends and family members. Responsibility can also be attributed to the general physicians and even some dermatologists to the extent that they did not emphasize the adverse effects and proper dosing of topical corticosteroids to the patients. This may also bring into focus the insufficient knowledge among medical/paramedical personnel about the proper use of topical corticosteroids. The Government has already taken legal steps in this regard but these steps alone are not sufficient. As a dermatologist we need to pledge that every steroid prescription is followed by proper counselling of the patient regarding TC usage so that a clear message is spread in the society and at the same time, patient should also be warned against self-medication and usage of these drugs.
Conclusion
In conclusion, the main responsibility for the misuse of topical corticosteroids can be attributed to chemists, the patient himself/herself, friends and family. Responsibility can also attributed be to general physicians and even some dermatologists to the extent that they did not emphasize the adverse effects and proper dosing of topical corticosteroids to the patients. Apart from this strict implementation of the Government policies is the need of the hour. Thus, educational and legal approaches need to go hand in hand to curb this rising epidemic.
